Symbio LLC has opened a new Phase I clinical unit in Michigan City, IN. Symbio provides clinical trial management, biometrics, consulting, product development and topical formulation development. With the addition of the Phase I Unit, the company can provide Phase I through Phase IV development. The Phase I unit has [...]

Teva announced yesterday that the FDA granted final approval to its ANDA for generic Risperdal (risperidone) tablets, that it was awarded 180-day exclusivity as the first paragraph IV filer for risperidone, and that it immediately commenced a commercial launch. FDA confirmed the final approval in a press release. Risperdal is [...]

Earlier this year, Amgen went out of its way to disavow a widely publicized case study that suggested Enbrel, which is only approved for treating rheumatoid arthritis and psoriasis, may be useful in combatting Alzheimer’s disease. In fact, the biotech issued successive press releases due to the single-patient case study, [...]

Shares of biotechnology company Celgene Corp. advanced Tuesday as a potential competitor to its bone-marrow cancer treatment in Europe failed a late-stage clinical trial. Read More Permalink[...]

At the National Institute for Neurological Disorders and Stroke in Bethesda, Maryland scientists are studying the effect an electric current applied to the scalp has on cognitive abilities of the subject. From MIT Technology Review: To explore how effective such stimulation can be as a learning tool, Eric Wassermann, a [...]

> Peregrine Pharmaceuticals has won a $44 million Department of Defense contract to test Bavituximab as a therapy for viral hemorrhagic fever infections. Story > Halozyme says that Chemophase met its primary endpoint in a continuing Phase I/IIa trial for superficial bladder cancer. Report > Adventrx Pharmaceuticals announced preliminary response [...]